Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 100,000 shares at $2.75 ($275K) on 2011-09-09, disclosed to the SEC on 2011-09-13.
Scheduled sale ($275k) by Senior VP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |